Clinical study of benign prostatic disease, current concepts and future prospects: Randomized controlled trials versus real life practice

Current Opinion in Urology

Volumn 13, Issue 1, 2003, Pages 1-5

  Chapple, Christopher R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; STEROID 5ALPHA REDUCTASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

CELL PROLIFERATION; CLINICAL EXAMINATION; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; EDITORIAL; EXTRACELLULAR MATRIX; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TRANSURETHRAL RESECTION;

AGED; BIOPSY, NEEDLE; EVIDENCE-BASED MEDICINE; FORECASTING; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHYTOTHERAPY; PROGNOSIS; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 0037243545     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200301000-00001     Document Type: Editorial

References (4)

1. Chatelain CH, Denis L, Foo KT, et al. Clinical research criteria for studies of LUTS. Recommendations of the 5th International Consultation on Benign Prostatic Hyperplasia; 25-28 June 2000; Paris. Plymouth, UK: Health Publication Ltd; 2001. pp. 317-396.
2. Bryan NP, Byrne L, Hastie KJ, et al. A pilot study for a randomized controlled trial comparing the efficacy, safety and cost-effectiveness of surgical treatments of the prostate. BJU Int 1999; 83:249-253.
3. Featherstone K, Donovan JL. Random allocation or allocation at random: patients perspectives of participation in a randomised controlled trial. BMJ 1998; 317:1177-1180.
4. Chapple CR on behalf of the Pan-European Expert Panel. Lower urinary tract symptoms suggestive of benign prostatic obstruction - Triumph: design and implementation. Eur Urol 2001; 39 (Suppl):31-36.